The following is a summary of “Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis,” published in the January 2025 issue of Psychiatry by Fountoulakis et al.

Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...

Both drugs were given on top of standard antidepressants to patients wo ... "This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers ...

Spravato (esketamine) has been touted as a potential ... if they have not responded adequately to at least two different antidepressants of adequate dose and duration in the current depressive ...

A new Cochrane review confirmed that antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs), are superior to placebo in ...

Starting a new antidepressant can bring relief, but it’s important to understand that side effects may occur as your body adjusts. Common effects like nausea, headaches, or mild dizziness are ...

Previous studies on relapse prevention showed promising results for tapering antidepressants with added relapse prevention. [29] Preventive cognitive therapy moreover showed promising long-term ...

A researcher is working on apps that he hopes will be able to identify signs of depression. The programs take and analyze photos of the eyes and face while someone uses the smartphone for other ...